Subgroups | Studies, n | Cases (n) | Prevalence (%) | 95% CI | Heterogeneity across the studies | Heterogeneity between groups (P-value) | |
---|---|---|---|---|---|---|---|
I2 | P-value | ||||||
Age(years) | |||||||
 <4 | 4 | 71 | 35.7% | 12.0-69.4 | 81.861 | 0.001 | 0.413 |
 ≥4 | 13 | 431 | 33.3% | 26.0-41.5 | 57.442 | 0.005 |  |
Continent | |||||||
 Europe | 5 | 128 | 30.9% | 19.8-44.8 | 51.534 | 0.083 | 0.008 |
 Asia | 6 | 122 | 29.0% | 13.5-51.8 | 76.986 | 0.001 |  |
 America | 10 | 434 | 36.6% | 30.1-43.6 | 44.143 | 0.065 |  |
Quality of studies | Â | ||||||
 High | 8 | 442 | 35.9% | 27.6-45.2 | 69.419 | 0.002 | 0.003 |
 Fair | 13 | 242 | 30.8% | 22.8-40.3 | 48.550 | 0.025 |  |
Time periods of studies | |||||||
 1976-2010 | 8 | 174 | 29.4% | 20.7-39.9 | 42.020 | 0.098 | 0.001 |
 2011-2023 | 13 | 510 | 35.2% | 27.6-43.7 | 66.012 |  |  |